It was also revealed that some miRNAs, such as miR-29a and miR-29b-1—which are involved in the regulation of APP and beta-site APP-cleaving enzyme 1 (BACE1) expression—were decreased in AD brains. Here, BACE1 is linked to Alzheimer disease.